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Abstract
The present study is an attempt to evaluate the antiproliferative potential of peptide (7.6 kDa) from
lionfish (Pterios volitans) venom on cultured HEp2 and HeLa cells. Different dose of purified peptide
(1, 2 and 4 μg/ml) at different time points (12, 24 and 36 hrs) were tested for antiproliferative index
of the peptide. Among them, 2 μg/ml at 24 hrs was found to effectively inhibit cancer cell growth
in vitro and did not cause any adverse effect on normal human lymphocytes. Apoptosis was
examined by propidium iodide staining, confirmed by the expression of caspase-8 and caspase-3,
down regulation of Bcl-2 expression and DNA fragmentation in treated cells, when compared to
untreated HEp2 and HeLa cells. Thus fish venom peptide was found to selectively induce apoptosis
in cancer cell.
Background
Cancer is the major public health burden in all developed
countries. Currently one in four death in the United States
is due to cancer [1]. In all types of cancer, genetic altera-
tions give rise to changes in expression, activation or local-
ization of regulatory proteins in the cells. They then affect
the signaling pathways that alter their response to regula-
tory stimuli and allow the unrestricted cell growth. Chem-
otherapeutic treatment strategies attempt directly to
inhibit proliferation of cancer cells or selectively remove
transformed cells by inducing apoptosis or eliminating
the cause of the growth advantage [2].
The approach of testing venoms as antitumour agents
dates back to the beginning of the last century, when Cal-
mette et al., [3] reported on the antitumour activity of
snake venom, (Naja species venom) in adenocarcinoma
cells. Since then many anticancer compounds have been
isolated from toxins of marine sponges e.g. Sesterstatin,
Dolastatin 10, Crellastatin and Ecteinascidin 743 from
tunicate is under Phase II clinical trial [4]. It was also dem-
onstrated that purified protein from cobra venom was
selectively cytotoxic to cancer cells [5,6]. Particularly, pro-
teinacious venom from several animals like snake, scor-
pion, spider etc., was reported to have excellent
cytotoxicity in cultured cancer cell lines and also reduces
tumor growth in mice [7,8]. Among all, snake venom has
been studied extensively however, the marked curative
properties of the snake venoms are always hindered by
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their high toxicities, and hence we selected a less toxic spe-
cies, scorpion fish venom for the present study.
Pterios volitans belongs to the family Scorpaenidae and
inhabits coral reef of the Indo-Pacific region and the Red
sea [9]. It is a relative of both stonefish (G.marmoratus)
and soldier fish (S.trachynis). P.volitans venom apparatus
consist of dorsal, anal and pelvic spines. Symptoms of
P.volitans envenomation resemble those of other fish of
family Scorpaenidae, in particular edema and extreme
pain associated with the site of injury. Systemic effects
such as vomiting, fever and sweating have been reported
[10]. Previous studies on P.volitans venom have observed
negative inotropic and chronotropic effects in vitro [11]
and depressor effects in vivo [12]. Previously we have
reported that lionfish venom reduces the tumour burden
and inhibits the metastasis in In vivo animal model [13].
However, the role of active component of the venom, its
molecular target and signaling pathways through which it
cause apoptosis in cancer cells is unknown.
But, unlike cancer cells, normal cells have intact pro-
grammed cell death mechanisms and most treatments
designed to kill cancer cells also reach normal cell, result-
ing in side effects to organs including the gastrointestinal
tract, bone marrow etc., The aim of the present study was
to purify the active peptide in the fish venom and to inves-
tigate its antiproliferative effect on cultured HEp2, HeLa
and normal lymphocytes In vitro and thereby its possible
mechanism of action.
Experimental procedures
Chemicals and reagents
The HEp2 (alveolar epithelial carcinoma cell line) and
HeLa (Cervial cancer line) cell lines were obtained from
National Center for Cell Science, Pune. All fine chemicals
were obtained from Sigma-Aldrich, St. Louis, MO, USA.
[3H]thymidine was from Amersham, UK. Bcl-2 antibody
was obtained from Santa Cruz Biotechnology, Inc. Santa
Cruz, California, Caspase-3 and 8 antibodies were
obtained from BD PharMingen, USA.
Venom preparation
Specimens of P.volitans  were obtained from the local
aquarium, killed (by cooling) and the venomous spines
were removed and stored in 10% glycerol solution at -
80°C and the venom was prepared as described by
Church and Hodgson [9]. The protein was estimated by
Lowry et al., [14]. The concentration was adjusted to 1.0
mg/ml, aliquoted and stored at -20°C till use.
Purification and MALDI-TOF analysis
The active crude fish venom was applied to sephadex G-50
column, equilibrated with 0.1 M phosphate buffer (potas-
sium dihydrogen phosphate and dipotassuim hydrogen
phosphate pH 7.4) and the fractions collected were
checked for activity on the HEp2 and HeLa cell lines. The
active fractions were pooled and the further concentrated
using a 10 kDa Amicon filter (Millipore corporation, Bill-
erica, MA, USA). The activity was once again determined
with the cell lines and run on the SDS-PAGE. Again the
purity was checked by the reverse phase HPLC using C18
column. A single peak with the retention time of 25 min
was obtained. Purification was carried out in three batches
under same experimental condition. The yield of the pure
peptide was 160 μg/ml and was pooled together to carry-
out the experiments.
Thus purified sample was submitted to Matrix-Assisted
Laser Desorption/Ionization (MALDI) Time-of-Flight
(TOF) mass spectrometry analysis using a Voyager-DE
PRO equipment (PerSeptive Biosystems) under the fol-
lowing conditions: accelerated voltage 25 kV, laser Wxed
at 2890_J/com2, and delay 300 ns, in the linear analysis
mode. Samples (10–50 pmol) were dissolved in 0.1%
(v:v) TFA in water and applied onto a target to determine
the molecular weight of the peptide.
in vitro antiproliferative assay using [3H]thymidine 
incorporation
HEp2 and HeLa cell lines were maintained in F-12 Dul-
becco's Modified Eagle Meduim (DMEM) supplemented
with 10% Fetal calf serum, amphotericin (3 μg/ml), gen-
tamycin (400 μg/ml), streptomycin (250 μg/ml), penicil-
lin (250 units/ml) in a carbon dioxide incubator at 5%
CO2.
In a 24 well plate [3H]thymidine (1 μci/ml of medium)
was added to the medium in which the cell line was
already maintained. 20 μl of different concentration (1, 2,
4 and 8 μg/ml) of the fish venom (FV) peptide was added
to the cells. Same volume of buffer was added to the con-
trol well. The cultures were trypsinized at the desired time
points, pelleted and washed sequentially with 10% and
5% tricholoroacetic acid and solublized in 0.1% sodium
hydroxide and 0.025% sodium dodecyl sulphate solu-
tion. The radioactivity of the samples was measured in the
Packard, TopCount. NXT™ Liquid scintillation counter
and expressed as cpm/mg protein. From the above exper-
iment an appropriate dose is selected and added to
human lymphocytes (isolated using histopaque – Sigma,
USA) to check the effect on normal cells.
MTT assay for cytotoxicity
HEp2 and HeLa cells were incubated in 96 wells plate (1
× 106 cells/ml) in the presence and absence of FV peptide
(2 μg/ml) for different time points (0, 12, 24, 36, 72 and
96 h). At the required time point 50 μl of supernatant was
aspirated, added to another well and mixed with 50 μl of
the substrate buffer containing MTT dye (provided in theJournal of Carcinogenesis 2006, 5:27 http://www.carcinogenesis.com/content/5/1/27
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Promega kit). The mixture was incubated for 30 minutes
at 15 to 25°C. Care was taken to keep the samples pro-
tected from light. After 30 minutes incubation 50 μl of the
stop solution was added and the absorbance was read on
an ELISA reader at 490 nm.
Raw absorbance readings were used to calculate the per-
centage cell death compared to that released by triton X-
100 detergent. Percent cell death was calculated as [(val-
ues from experimental condition) - (values from
untreated control)]/[(values from triton treated wells) -
(values from untreated control)] × 100. Each experiment
was performed at least 6 times to ensure consistency.
Detection of apoptosis
Propidium Iodide staining
HEp2 and HeLa cells were grown in a 6 well plate, FV pep-
tide and control drug were added and incubated for 24 hrs
and then cells were trypsinised and collected in micro-
centrifuge tubes. Cells were resuspended in 50 μl of PBS.
5 μl of RNase (1 mg/ml) and 5 μl of Propidium Iodide (25
μg/ml in PBS) was added and incubated at 37°C for one
hour. Fluorescence was excited with an Argon ion laser at
488 nm and visualized under Nikon Fluorescence micro-
scope.
Immunoblot analysis
Total cell lysate were prepared as reported by Narayana et
al., [15]. Proteins were separated on SDS 10% polyacryla-
mide gel. The gel was transferred onto a nitrocellulose
membrane (hybond C+, Amersham Life Sciences) at 220
mA for 3 h. The membrane was then washed with PBS and
blocking reagent (3% skimmed milk) was added and
blocked overnight at 4°C. Blocking reagent was washed
with PBS twice for 5 min each and primary antibody was
added (Bcl-2, caspase 3 and 8). One percent BSA in PBS,
0.1% Tween 20 was added to the blot along with the pri-
mary antibody (1:2000) and rocked gently at room tem-
perature for 1 h. The blot was washed three times with PBS
for 5 min each. Secondary antibody (1:5000) in 1% BSA
in PBS, 0.1% Tween 20 was allowed to hybridize for 1 h
at room temperature. The bands were detected using the
chromogenic substrate NBT-BCIP in alkaline phosphatase
buffer.
DNA fragmentation assay
Internucleosomal cleavage of DNA was analysed as given
below. Briefly, cells were treated with FV peptide (2 μg/
ml). The plate was incubated for required time points.
Cells were washed twice with ice-cold PBS and resus-
pended in lysis buffer containing 10 mM Tris – HCl (pH
8.0), 20 mM EDTA and 0.5% Triton X-100 and incubated
for 30 min in ice. After centrifugation at 10000 rpm for 10
min at 4°C, DNA was extracted with phenol chloroform,
precipitated with 0.1 vol 3 M sodium acetate and 2.5 vol
ethanol and stored at -20°C for overnight. DNA was pel-
leted by centrifugation at 10,000 rpm for 5 min at 4°C,
rinsed with 70% ethanol and then resuspended in TE
buffer (pH 8.0) containing, 30 μg/ml of RNase and incu-
bated for 6 hr at 37°C. DNA was run on a 2% agarose gel
with ethidium bromide staining [16]. After electrophore-
sis, DNA was visualized under UV and documented.
Statistical analysis
Values are expressed as means ± S.D of 6 repeats in each
group. Data within the groups were analyzed using one-
way analysis of variance (ANOVA) followed by Duncan's
Multiple Range Test (DMRT). A value of P < 0.05 was con-
sidered statistically significant.
Results
Purification of active peptide
MALDI-TOF spectrum showing the molecular weight of
purified peptide from the crude fish venom is illustrated
in the Fig. 1. This spectrum shows the presence of a single
intense peak with a molecular weight of 7.6 kDa. Thus
purified peptide was checked for its activity and used for
the further analysis.
Antiproliferative studies
The preliminary antiproliferative effect of fish venom (FV)
peptide on HEp2 and HeLa cell lines are shown in Fig.2.
[3H]thymidine incorporation studies were conducted in
three time points 12, 24 and 36 h. There was marked inhi-
bition of proliferation by FV at 24 h. The results are
expressed as counts of [3H]thymidine incorporated into
the actively proliferating cells per min per mg protein of
the cell mass. In the Fig. 2 the cell control and PBS control
shows the maximum counts of [3H]thymidine (around
36000 cpm/mg protein) when compared to the treatment
groups. Dose dependent study shows that 2 μg/ml of FV
showed the maximum inhibition (8500 and 9100 cpm/
mg protein for HEp2 and HeLa cells respectively) and this
same dose (2 μg/ml) did not show any cytotoxicity to the
normal human lymphocytes.
MTT assay for cytotoxicity
The cytotoxic effect was assed by the release of lactate
dehydrogenase (LDH) from HEp2 and HeLa cells after
treating with FV peptide at various time points did not
exceed 0.8% and suggest that the antiproliferative effect is
by induction of apoptosis in treated cells (Fig. 3). Hence
this dose alone was used for further studies.
Propidium Iodide staining to study nuclear morphology
Monolayer of HEp2 and HeLa cells were treated with FV
(2 μg/ml) and the extent of apoptosis was assessed by pro-
pidium iodide staining. The treated monolayer of HEp2
and HeLa cells contained more apoptotic cells when com-
pared to untreated monolayer (Fig. 4). There was charac-Journal of Carcinogenesis 2006, 5:27 http://www.carcinogenesis.com/content/5/1/27
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teristic nuclear fragmentation of nuclei in treated HEp2
and HeLa cells whereas; the untreated control cells did not
show any nuclear fragmentation. The apoptotic cells dis-
played the characteristic features of reduced size, intense
fluorescence of condensed nuclear chromatin and forma-
tion of membrane blebs. Similar results were observed
with same dose of venom extract on the HeLa cells.
Analysis of Caspase – 8, Caspase – 3 and Bcl-2 protein 
expression in HEp-2 cells
Immunoblot analysis of Caspase-8 and Caspase-3 in HEp-
2 and HeLa cells on exposure to FV (2 μg/ml) for 24 h
showed activation of Caspase-8 in treated cells (Fig 5A)
when compared to the untreated control cells. The acti-
vated caspase-8 in turn cleaves the pro caspase-3 (32 kDa)
into active Caspase-3 (17 kDa) (Fig. 5B). This is further
confirmed by the down regulation of Bcl-2 expression in
treated cells, which is actively expressed in the untreated
cells (Fig. 5C).
DNA fragmentation
Fig. 6 shows the agarose gel electrophoresis of chromo-
somal DNA isolated from the HEp2 and HeLa cells treated
with FV (2 μg/ml), along with untreated control. Lane 1
shows the marker, 100 bp DNA ladder. Lane 2 and 5
shows the intact DNA of the untreated HEp2 and HeLa
MALDI-TOF spectrum showing the molecular weight of the purified FV peptide Figure 1
MALDI-TOF spectrum showing the molecular weight of the purified FV peptide.Journal of Carcinogenesis 2006, 5:27 http://www.carcinogenesis.com/content/5/1/27
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cells, when compared to the fragmented DNA (HEp2 and
HeLa cells) of treated cells on Lane 3 and 4 respectively.
This study clearly demonstrates the DNA damage caused
by the fish venom extract when compared to the untreated
cells.
Discussion
Cancer cell cultures have been useful models to evaluate
gene expression and to establish in vitro experiments aim-
ing at the control of tumor cell growth [17]. One of the
major defects in cancer is the lack of cells to be driven into
the apoptotic mode, due to malfunction of molecules like
c-myc [18], ras [19], p53 [20], Bcl-2 [21], caspases [22]
and telomerase [23]. Hence we thought that, targeting
such molecules in cancer might provide a new therapeutic
strategy. With this background we tired to evaluate the
antiproliferative effect of fish venom (FV) peptide and
induction of apoptosis in cultured HEp2 and HeLa cells.
The antiproliferative effect was first evaluated by [3H]thy-
midine uptake of the actively proliferating cells. Among
the different doses tested at different time points, 2 μg/ml
at 24 h was found to produce a marked inhibition on the
HEp2 and HeLa cell proliferation and this dose did not
show any adverse effect on normal human lymphocytes.
At longer time points, 36 h, the antiproliferative effect was
reduced, which may be due to the effect of temperature on
MTT assay showing the cytotoxicity of FV peptide Figure 3
MTT assay showing the cytotoxicity of FV peptide.
Antiproliferative effect of FV peptide on HEp2 and HeLa cell  lines Figure 2
Antiproliferative effect of FV peptide on HEp2 and HeLa cell 
lines.
 Journal of Carcinogenesis 2006, 5:27 http://www.carcinogenesis.com/content/5/1/27
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the venom and needs to be investigated further. However,
fish venom was found to have selective sensitivity to can-
cer cells. Here, the question arises, whether the antiprolif-
erative effect is by apoptotic or necrotic pathway. This was
confirmed by MTT assay, the release of LDH is considered
to be of necrotic pathway and the treated cells showing
very less levels of LDH after 24 h suggests that the event of
cell death is by apoptosis. Lipps observed similar results
for the two protein fractions from snake venom, Atrop-
orin and Kaotree on SP/2 cell line [24]. Moreover, Greel
and Vaux [25] have suggested that a cancer cell treated
with a potentially lethal toxin will not die because of the
direct effects of toxin, but will activate its suicide mecha-
nism to die earlier by apoptosis. Thus in light of the previ-
ous findings it is evident that FV induces apoptosis
selectively in cancer cells.
shows the nuclear localization of HEp2 & HeLa cells by propidium iodide staining Figure 4
shows the nuclear localization of HEp2 & HeLa cells by propidium iodide staining. a and d are untreated HeLa and 
HEp2 cells respectively showing the intact cells without any nuclear fragmentation. b and e are actinomycin treated positive 
control. c and f are FV (2 μg/ml) treated cells showing the characteristic nuclear fragmentation and apoptotic bodies when 
compared to the untreated cells.
 
 FV (2μ μ μ μg/ml) treated HeLa
cells 
   Actinomycin D    treated
HeLa cells
 Untreated HeLa cells 
Untreated HEp2 
cells 
 Actinomycin treated 
HEp2 cells 
FV (2μ μ μ μg/ml) treated 
HEp2 cells Journal of Carcinogenesis 2006, 5:27 http://www.carcinogenesis.com/content/5/1/27
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shows the immunoblot of Caspase 3, 8 & Bcl-2 expression in untreated and treated HEp2 & HeLa cells Figure 5
shows the immunoblot of Caspase 3, 8 & Bcl-2 expression in untreated and treated HEp2 & HeLa cells. A. 
Expression of caspase 8. Lane 1 & 2 : untreated HEp2 and HeLa cells. Lane 3 & 4 : HEp2 & HeLa treated with FV (2 μg/ml). 
B. Expression of pro and active caspase 3. Lane1 & 2 : untreated HEp2 and HeLa cells. Lane 3 & 4 : HEp2 & HeLa treated 
with FV (2 μg/ml). C. Expression of Bcl -2. Lane 1 & 4 : untreated HEp2 and HeLa cells. Lane 2 & 3 : HEp2 & HeLa treated 
with FV (2 μg/ml). D. Expression of actin (loading control). Lane 1 & 4 : untreated HEp2 and HeLa cells. Lane 2 & 3 : HEp2 
& HeLa treated with FV (2 μg/ml)
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The role of apoptosis in cancer has been studied in detail.
Apoptosis being a highly regulated cellular response with
crucial checkpoints regulates the fate of cells. These check-
points are processing centers sensing extra cellular signals,
amplifying localized signals, integrating information
form these cells and directing them towards death cascade
[26]. One of the targets of oncogene-induced sensitization
is the mitochondria and c-myc facilitates cytochrome c
release from the mitochondria [27]. The released cyto-
chrome c activates the caspases, a family of cysteine pro-
tease and suppresses Bcl-2 thereby causing apoptosis
through intrinsic pathway [28].
The possible role of apoptosis in the present study was
first examined with propidium iodide staining of treated
and untreated cells. The nuclear fragmentation (fig. 5)
clearly demonstrates the role of apoptosis in FV treated
cells and motivated to further analyze the expression of
certain apoptotic markers. Expression of caspase-8 was
observed in the FV treated cells when compared to
untreated cells, which in turn was believed to activate the
procaspase-3 to active caspase-3 [29]. FV treatment was
also found to down regulate the expression of Bcl-2 when
compared to cancer control. Hence it is obvious that FV
peptide selectively targets the cancer cells sparing the nor-
mal ones.
The caspase-activated cascade finally results in the DNA
fragmentation. Willey has suggested that, during apopto-
sis a specific nuclease cuts the genomic DNA between
nucleosomes to generate DNA fragments, and the pres-
ence of this ladder has been extensively used as a marker
for apoptotic cell death [30]. Nagata also showed that, the
DNA ladder nuclease (now known as caspase activated
DNase or CAD) pre-exists in living cells as an inactive
complex with an inhibitor subunit. Activation of CAD
occurs by means of caspase-3-mediated cleavage of inhib-
itory subunit, resulting in the release and activation of the
catalytic subunit [31]. The observed result, activation of
caspases and DNA fragmentation demonstrates the role of
FV in apoptosis of HEp2 cells.
Till date many toxins and proteins have been reported to
induce apoptosis in the cancer cell by activating the
enzymes of the apoptotic cascade [32,33]. Previously, we
have reported that lionfish venom induces apoptosis in
Ehrlich's ascites carcinoma xenografted mice by activating
caspase-3, which was evidenced by nuclear fragmentation
[13]. In this context, Snyder et al., [34] has suggested a
hypothesis of anti-cancer gene therapy, which says that,
replacement of tumor suppressor gene functions in malig-
nant cell will result in specific death or apoptosis of the
cancer cell, while sparing the surrounding normal cells.
We have reported the anticancer effect of fish venom for
the first time in the In vitro cancer model.
Hence the present study clearly demonstrate that FV pep-
tide targets the actively proliferating cancer cells by induc-
ing the apoptotic pathway and mechanism by which the
induction is made is yet to be resolved.
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